SCHEMBL1102346

SCHEMBL1102346

CCCCCCCCc1ccc(-c2ccc(Br)s2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.48
RAB9A P51151 2/20 0.48
HSD17B10 Q99714 3/20 0.47
TSHR P16473 1/20 0.47
ALDH1A1 P00352 3/20 0.47
ESR1 P03372 2/20 0.47
ADRA2A P08913 2/20 0.47
ADORA3 P0DMS8 2/20 0.47
TACR2 P21452 2/20 0.47
SLC6A2 P23975 2/20 0.47
SLC6A4 P31645 2/20 0.47
SLC6A3 Q01959 2/20 0.47
LMNA P02545 1/20 0.47
SHBG P04278 1/20 0.47
TP53 P04637 1/20 0.47
CYP3A4 P08684 1/20 0.47
HSPD1 P10809 1/20 0.47
ADRB3 P13945 1/20 0.47
HTR2C P28335 1/20 0.47
HSPE1 P61604 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21980890 1.00 KDM4E (0.48) KDM4ERAB9AHSD17B10TSHRALDH1A1
SCHEMBL15071811 1.00 KDM4E (0.48) KDM4ERAB9AHSD17B10TSHRALDH1A1
SCHEMBL15070058 0.97 KDM4E (0.46) KDM4ERAB9AHSD17B10TSHRALDH1A1
SCHEMBL1102350 0.97 KDM4E (0.46) KDM4ERAB9AHSD17B10TSHRALDH1A1
SCHEMBL2466020 0.88 HSD17B10 (0.55) KDM4ERAB9AHSD17B10TSHRALDH1A1
SCHEMBL6418801 0.88 HSD17B10 (0.55) KDM4ERAB9AHSD17B10TSHRALDH1A1
SCHEMBL6418550 0.86 HSD17B10 (0.57) KDM4ERAB9AHSD17B10TSHRALDH1A1
SCHEMBL6422261 0.86 HSD17B10 (0.53) KDM4ERAB9AHSD17B10TSHRALDH1A1
SCHEMBL6421748 0.86 HSD17B10 (0.53) KDM4ERAB9AHSD17B10TSHRALDH1A1
SCHEMBL4449126 0.86 HSD17B10 (0.53) KDM4ERAB9AHSD17B10TSHRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8716703-B2 Organic semiconductor transistor FUJI XEROX CO., LTD. (JP) 2014-05-06 US disclosed
US-20130161589-A1 ORGANIC SEMICONDUCTOR TRANSISTOR FUJI XEROX CO., LTD. (JP) 2013-06-27 US disclosed
US-8153822-B2 Fluorene compound FUJI XEROX CO., LTD. (JP) 2012-04-10 US disclosed
US-20100197942-A1 NOVEL FLUORENE COMPOUND FUJI XEROX CO., LTD. (JP) 2010-08-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100197942-A1 NOVEL FLUORENE COMPOUND AFF1, AFF2, FLI1 KDM4E 4551/4885RAB9A 301/4885HSD17B10 2172/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.